The role of sentinel lymph node biopsy for thin cutaneous melanomas of the head and neck

American Journal of Otolaryngology - Head and Neck Medicine and Surgery

Volumn 35, Issue 2, 2014, Pages 226-232

  Kupferman, Michael E ^a   Kubik, Mark W ^b   Bradford, Carol R ^c   Civantos, Francisco J ^d   Devaney, Kenneth O ^e   Medina, Jesus E ^f   Rinaldo, Alessandra ^g   Stoeckli, Sandro J ^h   Takes, Robert P ⁱ   Ferlito, Alfio ^g  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MIAMI   (United States)

^e Allegiance Health ^*  (United States)

^f UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^g UNIVERSITY OF UDINE   (Italy)

^h CANTONAL HOSPITAL ST GALLEN   (Switzerland)

ⁱ RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; AGE; ARTICLE; CANCER CLASSIFICATION; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CLINICAL FEATURE; CUTANEOUS MELANOMA; CUTANEOUS MELANOMA OF THE HEAD AND NECK; HEAD AND NECK TUMOR; MITOSIS RATE; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE METASTASIS; SEX DIFFERENCE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR REGRESSION; ULCER;

DIAGNOSIS, DIFFERENTIAL; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MELANOMA; NECK; REPRODUCIBILITY OF RESULTS; SENTINEL LYMPH NODE BIOPSY;

EID: 84896700326     PISSN: 01960709     EISSN: 1532818X     Source Type: Journal    
DOI: 10.1016/j.amjoto.2013.12.004     Document Type: Review

References (44)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
2. N. Howlader, A.M. Noone, and M. Krapcho et al. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD http://seer.cancer.gov/csr/1975-2009-pops09 [Accessed 6/10/12]
3. M.N. Younes, and J.N. Myers Melanoma of the head and neck: current concepts in staging, diagnosis, and management Surg Oncol Clin N Am 13 2004 201 229
4. A.M. Lachiewicz, M. Berwick, and C.L. Wiggins et al. Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program Arch Dermatol 144 2008 515 521 10.1001/archderm.144.4.515
5. C.M. Balch, J.E. Gershenwald, and S.J. Soong et al. Final version of 2009 AJCC melanoma staging and classification J Clin Oncol 19 2001 3635 3648
6. A.C. Green, P. Basade, and M. Coory et al. Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia J Clin Oncol 30 2012 1462 1467
7. D.L. Morton, L. Wanek, and J.A. Nizze et al. Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes: analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic J Clin Oncol 15 1997 1039 1051
8. D.L. Morton, J.F. Thompson, and R. Essner et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma Ann Surg 230 1999 453 463 [discussion 463-5]
9. I. Pathak, C.J. O'Brien, and K. Petersen-Schaeffer et al. Do nodal metastases from cutaneous melanoma of the head and neck follow a clinically predictable pattern? Head Neck 23 2001 785 790
10. N. de Rosa, G.H. Lyman, and D. Silbermins et al. Sentinel node biopsy for head and neck melanoma: a systematic review Otolaryngol Head Neck Surg 145 2011 375 382
11. E.H. Doting, M. de Vries, and J.T. Plukker et al. Does sentinel lymph node biopsy in cutaneous head and neck melanoma alter disease outcome? J Surg Oncol 93 2006 564 570
12. S.P. Leong, N.A. Accortt, and R. Essner et al. Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients Arch Otolaryngol Head Neck Surg 132 Apr 2006 370 373
13. J.E. Gershenwald, D.G. Coit, and V.K. Sondak et al. The challenge of defining guidelines for sentinel lymph node biopsy in patients with thin primary cutaneous melanoma Ann Surg Oncol 19 Oct 2012 3301 3303
14. B.E. Wright, R.P. Scheri, and X. Ye et al. Importance of sentinel lymph node biopsy in patients with thin melanoma Arch Surg 143 2008 892 899 [discussion 899-900]
15. M. Faries, L. Wanek, and D. Elashoff et al. Predictors of occult nodal metastasis in patients with thin melanoma Arch Surg 145 2010 137 142
16. D.G. Coit, R. Andetbacka, and C.K. Bichakjian et al. NCCN clinical practice guidelines in oncology: melanoma Available at http://www.nccn.org [Accessed May 22, 2012]
17. R. Andtbacka, and J. Gershenwald Role of sentinel lymph node biopsy in patients with thin melanoma J Natl Compr Cancer Netw 7 2009 3009 3017
18. M.S. Sabel Sentinel lymph node biopsy for thin melanoma J Surg Oncol 106 2012 217 218
19. S.L. Wong, M.S. Brady, and K.J. Busam et al. Results of sentinel lymph node biopsy in patients with thin melanoma Ann Surg Oncol 13 2006 302
20. C.M. Balch, S.J. Soong, and H.M. Shaw et al. An analysis of prognostic factors in 8,500 patients with cutaneous melanoma C.M. Balch, A.N. Houghton, G.W. Milton, A.J. Sober, S.J. Soong, Cutaneous melanoma 2nd ed. 1992 Lippincott Philadelphia 165 187
21. N. Fadaki, R. Li, and B. Parrett et al. Is head and neck melanoma different from trunk and extremity melanomas with respect to sentinel lymph node status and clinical outcome? Ann Surg Oncol 20 2013 3089 3097
22. L.A. Kilpatrick, P. Shen, and J.H. Stewart et al. Use of sentinel lymph node biopsy for melanoma of the head and neck Am Surg 73 2007 754 758
23. S.R. Fisher, H.F. Seigler, and S.L. George Therapeutic and prognostic considerations of head and neck melanoma Ann Plast Surg 28 1992 78 80
24. C.G. Callender, M.E. Egger, and A.L. Burton et al. Prognostic implications of anatomic location of primary cutaneous melanoma 1 mm or thicker Am J Surg 202 2011 659 664
25. R. Murali, L.E. Haydu, and M.J. Quin et al. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma Ann Surg 255 2012 128 133
26. B.E. Saltman, I. Ganly, and S.G. Patel Prognostic implication of sentinel lymph node biopsy in cutaneous head and neck melanoma Head Neck 32 2010 Dec 1686 1692
27. A. Erman, R. Collar, and K.A. Griffith et al. Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma Cancer 118 2012 1040 1047
28. J. Jaber, J. Clark, and K. Muzaffar et al. Evolving treatment strategies in thin cutaneous head and neck melanoma: 1 institution experience Head Neck 33 2011 7 12
29. S.A. Sekula-Gibbs, and M.A. Shearer Sentinel lymph node biopsy should be offered in thin melanoma with mitotic rate greater than one Dermatol Surg 37 2011 1080 1088
30. P.A. Gimotty, and D. Guerry Prognostication in thin cutaneous melanomas Arch Pathol Lab Med 134 Dec 2010 1758 1763
31. P.A. Gimotty, D. Guerry, and M.E. Ming et al. Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging J Clin Oncol 22 2004 3668 3676
32. M.F. Azzola, H.M. Shaw, and J.F. Thompson et al. Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center Cancer 97 2003 1488 1498
33. K. Blessing, and K.M. McLaren Histological regression in primary cutaneous melanoma: recognition, prevalence, and significance Histopathology 20 1992 315 322
34. S.E. McClain, A.L. Shada, and M. Barry et al. Outcome of sentinel lymph node biopsy and prognostic implications of regression in thin malignant melanoma Melanoma Res 22 2012 302 309
35. L.L. Kruper, F.R. Spitz, and B.J. Czerniecki et al. Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma Cancer 107 2006 2436 2445
36. V.K. Sondak, J.M. Taylor, and M.S. Sabel et al. Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model Ann Surg Oncol 11 2004 259 264
37. S. Pasquali, A.J. Spillane, and J.H. de Wilt et al. Surgeons' opinions on lymphadenectomy in melanoma patients with positive sentinel nodes: a Worldwide Web-based survey Ann Surg Oncol 19 2012 4322 4329
38. D.L. Morton, J.F. Thompson, and A.J. Cochran et al. Sentinel-node biopsy or nodal observation in melanoma N Engl J Med 355 2006 1307 1317
39. K. McDonald, A.J. Page, and S.W. Jordan et al. Analysis of regional recurrence after negative sentinel lymph node biopsy for head and neck melanoma Head Neck 35 May 2013 667 671
40. J.E. Gershenwald, R.H. Andtbacka, and V.G. Prieto et al. Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma J Clin Oncol 26 2008 4296 4303
41. F. Gomez-Rivera, A. Santillan, and A.B. McMurphey et al. Sentinel node biopsy in patients with cutaneous melanoma of the head and neck: recurrence and survival study Head Neck 30 Oct 2008 1284 1294
42. D.M. Agnese, S.F. Abdessalam, and W.E. Burak Jr. et al. Cost-effectiveness of sentinel lymph node biopsy in thin melanomas Surgery 134 2003 542 547
43. P.A. Gimotty, and D. Guerry Thin melanoma prognosis - Melanoma Molecular Map Project http://www.mmmp.org/MMMP/import.mmmp?page=risk-ass-progn-thin.mmmp 2010 [Accessed 8/5/12]
44. P.A. Gimotty, P. Van Belle, and D.E. Elder et al. Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma J Clin Oncol 23 2005 8048 8056